Sp100 nuclear antigen
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Sp100 nulcear antigen | |
|---|---|
| Symbol(s): | SP100 |
| Genetic data | |
| Locus: | Chr. 2 q37.1 |
| Gene code: | SP100 |
| Protein Structure/Function | |
| Molecular Weight: | 100k (Da) |
| Functions: | Normal-unknown |
| Other | |
| Taxa expressing: | Homo sapiens |
| Cell types: | All |
| Subcellular localization: | Nucleoplasm, Chromatin |
| Molecular interactions: | Autoantigenic |
| Enzymatic Data | |
| Cofactor(s): | NUPs |
| Database Links | |
| Accession Numbers: | AF056322 |
| Entrez: | 6672 |
| OMIM: | 604585 |
| PDB: | 1H5P |
| RefSeq: | NM_003113 |
| UniProt: | P23497 |
Sp100 nuclear antigen is an interferon stimulated antigen found in the bile duct of primary biliary cirrhosis.[1] Histologically sp100 'dots' regions of the cell nucleus. Viral infection and mitogens affect the expression of the Sp100 autoantigen. Cells grown in the presence of interferons(α,β, and γ)revealed an increase both in size and number of the Sp100 protein-containing nuclear dots and increase the protein concentration. This raises "the question whether cytokine-mediated increase of Sp100 protein expression plays a role in induction of anti-Sp100 autoantibodies."[2]
Sp100 and Nuclear Dots
Two proteins, sp100 and Promycrocytic leukemia (PML) factor are localized to punctate domains in the nucleus (nuclear dots or nuclear bodies). These domains (few to 20) were found to form a donut shaped structure when cells were starved of amino acids. In particular, depravation of cystine results in most pronounced changes.[3] Two other proteins, PIC1/SUMO-1, that also interact with nuclear pore complex factors also interact with these two proteins.[4] In addition sp100 interacts with a chromatin binding protein, HM1.[5]
Sp100 Splicoforms
Some sp100 variants contain a domain similar to two interferon-inducible nuclear phosphoproteins, suppressin and DEAF-1. This defines a novel protein motif, the HNPP-box. Another class of variants has high mobility group 1 (HMG1) protein sequence as a domain. Both major classes of Sp100 splice variant proteins localize in part to nuclear dots/PML bodies and other nuclear domains. [6]
References
- ↑ Szostecki C, Guldner HH, Netter HJ, Will H (1990). "Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis". J. Immunol. 145 (12): 4338-47. PMID 2258622.
- ↑ Guldner HH, Szostecki C, Grötzinger T, Will H (1992). "IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis". J. Immunol. 149 (12): 4067-73. PMID 1281200.
- ↑ Kamei H (1997). "Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells". Exp. Cell Res. 237 (1): 207-16. doi:10.1006/excr.1997.3790. PMID 9417884.
- ↑ Sternsdorf T, Jensen K, Will H (1997). "Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1". J. Cell Biol. 139 (7): 1621-34. PMID 9412458.
- ↑ Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A (1998). "Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment". Proc. Natl. Acad. Sci. U.S.A. 95 (13): 7316-21. PMID 9636146.
- ↑ Guldner HH, Szostecki C, Schröder P, et al (1999). "Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif". J. Cell. Sci. 112 ( Pt 5): 733-47. PMID 9973607.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
